EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma [clinicaltrials:NCT00004261]
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma [clinicaltrials:NCT00004261]
Bio2RDF identifier
NCT00004261
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00004261
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: EF5 may dete ...... gh grade soft tissue sarcoma.
brief title [clinicaltrials_vocabulary:brief-title]
EF5 Prior to Surgery or Biopsy ...... High Grade Soft Tissue Sarcoma
collaborator [clinicaltrials_vocabulary:collaborator]
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES: I. Determin ...... dy within 12-18
months.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2000-01-28T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
keyword [clinicaltrials_vocabulary:keyword]
breast cancer in situ
inflammatory breast cancer
recurrent adult soft tissue sarcoma
recurrent breast cancer
recurrent cervical cancer
recurrent hypopharyngeal cancer
recurrent laryngeal cancer
recurrent lip and oral cavity cancer
recurrent metastatic squamous neck cancer with occult primary
recurrent nasopharyngeal cancer
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2011-02-18T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00004261
official title [clinicaltrials_vocabulary:official-title]
A Phase I Trial of the Hypoxia ...... igh Grade Soft Tissue Sarcomas
org study id [clinicaltrials_vocabulary:org-study-id]
CDR0000067516
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
secondary id [clinicaltrials_vocabulary:secondary-id]
CAN-OCI-T98-0048
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1999-12-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2002-06-01T00:00:00Z
identifier
clinicaltrials:NCT00004261
title
EF5 Prior to Surgery or Biopsy ...... High Grade Soft Tissue Sarcoma
@en
type
label
EF5 Prior to Surgery or Biopsy ...... a [clinicaltrials:NCT00004261]
@en